BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 2559316)

  • 21. Interaction between DNA gyrase and quinolones: effects of alanine mutations at GyrA subunit residues Ser(83) and Asp(87).
    Barnard FM; Maxwell A
    Antimicrob Agents Chemother; 2001 Jul; 45(7):1994-2000. PubMed ID: 11408214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. gyrB mutations which confer coumarin resistance also affect DNA supercoiling and ATP hydrolysis by Escherichia coli DNA gyrase.
    Contreras A; Maxwell A
    Mol Microbiol; 1992 Jun; 6(12):1617-24. PubMed ID: 1323022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of action of quinolones against Escherichia coli DNA gyrase.
    Yoshida H; Nakamura M; Bogaki M; Ito H; Kojima T; Hattori H; Nakamura S
    Antimicrob Agents Chemother; 1993 Apr; 37(4):839-45. PubMed ID: 8388200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA supercoiling in a thermotolerant mutant of Escherichia coli.
    Friedman SM; Malik M; Drlica K
    Mol Gen Genet; 1995 Aug; 248(4):417-22. PubMed ID: 7565605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycobacterial DNA gyrase: enzyme purification and characterization of supercoiling activity.
    Wu LC; Shahied SI
    Arch Biochem Biophys; 1995 Dec; 324(1):123-9. PubMed ID: 7503546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene.
    Kumagai Y; Kato JI; Hoshino K; Akasaka T; Sato K; Ikeda H
    Antimicrob Agents Chemother; 1996 Mar; 40(3):710-14. PubMed ID: 8851598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli.
    Yoshida H; Bogaki M; Nakamura M; Nakamura S
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1271-2. PubMed ID: 2168148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa.
    Yoshida H; Nakamura M; Bogaki M; Nakamura S
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1273-5. PubMed ID: 2168149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acid.
    Cambau E; Bordon F; Collatz E; Gutmann L
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1247-52. PubMed ID: 8392306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations.
    Ouabdesselam S; Hooper DC; Tankovic J; Soussy CJ
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1667-70. PubMed ID: 7486897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli.
    Heisig P; Schedletzky H; Falkenstein-Paul H
    Antimicrob Agents Chemother; 1993 Apr; 37(4):696-701. PubMed ID: 8388197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interactions of subunits of DNA gyrase].
    Bogdanova ES; Mirkin SM; Shmerling ZhG
    Mol Biol (Mosk); 1982; 16(5):1019-25. PubMed ID: 6292700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequence analysis, purification, and study of inhibition by 4-quinolones of the DNA gyrase from Mycobacterium smegmatis.
    Revel-Viravau V; Truong QC; Moreau N; Jarlier V; Sougakoff W
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2054-61. PubMed ID: 8878580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory activity of quinolones against DNA gyrase of Mycobacterium tuberculosis.
    Onodera Y; Tanaka M; Sato K
    J Antimicrob Chemother; 2001 Apr; 47(4):447-50. PubMed ID: 11266418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones.
    Cullen ME; Wyke AW; Kuroda R; Fisher LM
    Antimicrob Agents Chemother; 1989 Jun; 33(6):886-94. PubMed ID: 2548439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones.
    Ferrero L; Cameron B; Manse B; Lagneaux D; Crouzet J; Famechon A; Blanche F
    Mol Microbiol; 1994 Aug; 13(4):641-53. PubMed ID: 7997176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression in Escherichia coli of Y5-mutant and N-terminal domain-deleted DNA gyrase B proteins affects strongly plasmid maintenance.
    Brino L; Mousli M; Oudet P; Weiss E
    Plasmid; 1997; 38(3):188-201. PubMed ID: 9435021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
    Yasuda M; Fukuda H; Yokoi S; Ishihara S; Kawada Y; Deguchi T
    J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
    J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the NH2-terminal 87th amino acid of Escherichia coli GyrA in quinolone-resistance.
    Yonezawa M; Takahata M; Banzawa N; Matsubara N; Watanabe Y; Narita H
    Microbiol Immunol; 1995; 39(7):517-20. PubMed ID: 8569537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.